Spectral AI Announces 2025 Second Quarter Financial Results

(NASDAQ:MDAI),(NASDAQ:MDAIW), Q2 Overview Research & Development Revenue of $5.1 Million, total revenue for the first half of 2025 of $11.8 Million Strong Cash position of $10.5 Million Submission of De Novo application to FDA completed in Second Quarter of 2025 DALLAS, Aug. 12, 2025 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or […]

Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update

Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update GlobeNewswire August 12, 2025 PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for efficacy following review by independent data monitoring committee (IDMC) Spero, along with its development partner, GSK, plans to submit data from

Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock

(TSX:EDT), Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary endpoint: 90-day Mortality 17.4% lower with PMX and >99% posterior probability of benefit 38.7% Mortality at 28 days with PMX confirms results of prior trial

Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease

(NASDAQ:CGTX), – Cognition and FDA align on enriched population, study design, and endpoints – PURCHASE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, received final minutes from the U.S. Food and Drug Administration (FDA) pertaining to the end-of-Phase

IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NASDAQ:IRBT), NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or “the Company”) (NASDAQ: IRBT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

DDD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that 3D Systems Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NYSE:DDD), NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against 3D Systems Corporation (“3D Systems” or “the Company”) (NYSE: DDD) and certain of its officers. Class Definition This lawsuit seeks to recover

TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NASDAQ:TEM), NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or “the Company”) (NASDAQ: TEM) and certain of its officers. Class Definition This lawsuit seeks to recover damages

TSLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tesla, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NASDAQ:TSLA), NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tesla, Inc. (“Tesla” or “the Company”) (NASDAQ: TSLA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

WOOF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Petco Health and Wellness Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NASDAQ:WOOF), NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Petco Health and Wellness Company, Inc. (“Petco” or “the Company”) (NASDAQ: WOOF) and certain of its officers. Class Definition This lawsuit seeks

Pathway Health Recognized as a 2025 Minnesota Star Tribune National Standard Top Workplace for the Third Consecutive Year

Pathway Health Recognized as a 2025 Minnesota Star Tribune National Standard Top Workplace for the Third Consecutive Year GlobeNewswire August 12, 2025 LAKE ELMO, Minn., Aug. 12, 2025 (GLOBE NEWSWIRE) — Pathway Health, a leading provider of health care consulting services, interim and permanent leadership, technology implementation, and training solutions, has been recognized as a

Scroll to Top